JPWO2019211668A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019211668A5 JPWO2019211668A5 JP2021510564A JP2021510564A JPWO2019211668A5 JP WO2019211668 A5 JPWO2019211668 A5 JP WO2019211668A5 JP 2021510564 A JP2021510564 A JP 2021510564A JP 2021510564 A JP2021510564 A JP 2021510564A JP WO2019211668 A5 JPWO2019211668 A5 JP WO2019211668A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- mixture
- composition according
- pharmaceutically acceptable
- neurosteroid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862667100P | 2018-05-04 | 2018-05-04 | |
| US62/667,100 | 2018-05-04 | ||
| US16/403,100 | 2019-05-03 | ||
| US16/403,100 US20190337975A1 (en) | 2018-05-04 | 2019-05-03 | Neurosteroid derivatives and uses thereof |
| PCT/IB2019/000517 WO2019211668A2 (en) | 2018-05-04 | 2019-05-03 | Neurosteroid derivatives and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021523938A JP2021523938A (ja) | 2021-09-09 |
| JP2021523938A5 JP2021523938A5 (https=) | 2022-05-02 |
| JPWO2019211668A5 true JPWO2019211668A5 (https=) | 2022-05-02 |
Family
ID=68384780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510564A Pending JP2021523938A (ja) | 2018-05-04 | 2019-05-03 | 神経ステロイド誘導体およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20190337975A1 (https=) |
| EP (1) | EP3788055A4 (https=) |
| JP (1) | JP2021523938A (https=) |
| CN (1) | CN112823164A (https=) |
| AR (1) | AR116659A1 (https=) |
| AU (1) | AU2019264032A1 (https=) |
| CA (1) | CA3099089A1 (https=) |
| PY (1) | PY1934080A (https=) |
| TW (1) | TW202014192A (https=) |
| UY (1) | UY38213A (https=) |
| WO (1) | WO2019211668A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201606063RA (en) | 2012-01-23 | 2016-09-29 | Sage Therapeutics Inc | Neuroactive steroid formulations and methods of treating cns disorders |
| MX2015002252A (es) | 2012-08-21 | 2015-07-21 | Sage Therapeutics Inc | Metodos para tratar epilepsia o estado de epilepsia. |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| JP6470258B2 (ja) | 2013-04-17 | 2019-02-13 | セージ セラピューティクス， インコーポレイテッド | １９−ノルｃ３，３−ジ置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法 |
| ES2848823T3 (es) | 2013-08-23 | 2021-08-12 | Sage Therapeutics Inc | Esteroides neuroactivos, composiciones y usos de los mismos |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| US10577390B2 (en) | 2014-10-16 | 2020-03-03 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| ME03809B (me) | 2014-10-16 | 2021-04-20 | Sage Therapeutics Inc | KOMPOZICIJE I POSTUPCI ZA LEČENJE POREMEĆAJA CNS-a |
| WO2016123056A1 (en) | 2015-01-26 | 2016-08-04 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| HK1258616A1 (zh) | 2016-03-08 | 2019-11-15 | Sage Therapeutics, Inc. | 神经活性类固醇、组合物、及其用途 |
| US20190233465A1 (en) | 2016-07-11 | 2019-08-01 | Sage Therapeutics, Inc. | C7, c12, and c16 substituted neuroactive steroids and their methods of use |
| MA45599A (fr) | 2016-07-11 | 2019-05-15 | Sage Therapeutics Inc | Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation |
| CR20240234A (es) | 2019-05-31 | 2024-07-09 | Sage Therapeutics Inc | ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629) |
| CN115348864A (zh) * | 2020-02-05 | 2022-11-15 | 纯技术Lyt股份有限公司 | 神经甾体的脂质前药 |
| MX2022010620A (es) * | 2020-02-27 | 2022-11-30 | Brii Biosciences Inc | Profarmacos de esteroides neuroactivos. |
| IL315509A (en) * | 2022-03-18 | 2024-11-01 | Marinus Pharmaceuticals Inc | Genaxolone medication matrims |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB748846A (en) * | 1953-10-28 | 1956-05-09 | Vitamins Ltd | A process for the manufacture of pregnan-3(-a)-ol-20-one and derivatives thereof |
| US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| KR100338287B1 (ko) * | 1994-02-14 | 2002-11-30 | 푸르듀 파머 리미티드 | 감마-아미노부티르산a수용체의알로오스테리조절용안드로스탄및프레그난 |
| US20060009432A1 (en) * | 2004-07-09 | 2006-01-12 | Roger Whiting | Use of neurosteroids to treat neuropathic pain |
| WO2011120044A1 (en) * | 2010-03-26 | 2011-09-29 | Duke University | Conjugated neuroactive steroid compositions and methods of use |
| FR2973031B1 (fr) * | 2011-03-23 | 2013-11-29 | Univ Strasbourg | Derives de l'allopregnanolone et de l'epiallopregnanolone et leurs utilisations pour traiter un etat neuropathologique |
| US20170022245A1 (en) * | 2013-11-26 | 2017-01-26 | Biopharma Works | Ganaxolone derivatives for treatment of central nervous systems disorders |
| EP3641779B1 (en) * | 2017-06-23 | 2024-02-28 | The Board of Trustees of the University of Illinois | Treatment of neuropsychiatric disorders with neurosteroids and analogues thereof |
| CN109666055A (zh) * | 2017-10-16 | 2019-04-23 | 张家口华健致远生物科技有限公司 | 调节中枢神经治疗抑郁症的化合物及其用途 |
-
2019
- 2019-05-03 US US16/403,100 patent/US20190337975A1/en not_active Abandoned
- 2019-05-03 WO PCT/IB2019/000517 patent/WO2019211668A2/en not_active Ceased
- 2019-05-03 CA CA3099089A patent/CA3099089A1/en active Pending
- 2019-05-03 TW TW108115447A patent/TW202014192A/zh unknown
- 2019-05-03 AU AU2019264032A patent/AU2019264032A1/en not_active Abandoned
- 2019-05-03 EP EP19796480.2A patent/EP3788055A4/en not_active Withdrawn
- 2019-05-03 AR ARP190101187A patent/AR116659A1/es not_active Application Discontinuation
- 2019-05-03 PY PY201901934080A patent/PY1934080A/es unknown
- 2019-05-03 UY UY38213A patent/UY38213A/es unknown
- 2019-05-03 JP JP2021510564A patent/JP2021523938A/ja active Pending
- 2019-05-03 CN CN201980033110.9A patent/CN112823164A/zh active Pending
-
2021
- 2021-08-02 US US17/392,004 patent/US20210363173A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523938A5 (https=) | ||
| JPWO2019211668A5 (https=) | ||
| DE60114145T3 (de) | Fulvestrant formulierung | |
| CA2869676C (en) | Uses and compositions comprising a thiazolidinedione and oleic acid for locally increasing subcutaneous fat | |
| CN100352433C (zh) | 用于治疗炎症的脂肪醇和脂肪酸酯 | |
| ES2745458T3 (es) | Uso de PUFAS para el tratamiento de la inflamación de la piel | |
| US20210363173A1 (en) | Neurosteriod derivatives and uses thereof | |
| EP1295600B1 (de) | Arzneimittel auf Basis von Gestagenen zur dermalen Anwendung enthaltend Ascorbinsäure sowie deren Salze | |
| GB2128087A (en) | Topically administrable anti-inflammatory pharmaceutical compositions | |
| JPS6245845B2 (https=) | ||
| CN1248738C (zh) | 用于人的睾酮酯制剂 | |
| HU197840B (en) | Process for producing synergic pharmaceutical compositions comprising amantadin and selegilin | |
| FR2862540A1 (fr) | Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile | |
| EP0973524B1 (fr) | Utilisation cosmetique ou dermatologique de steroides 7-hydroxyles | |
| DE60011748T2 (de) | Methoden und zusammenstellungen zur behandlung der weiblichen sexuellen dysfunktion | |
| JP2014001247A (ja) | １１−デオキシ−プロスタグランジン化合物を含む医薬組成物およびその安定化方法 | |
| JPS6341887B2 (https=) | ||
| JP2005528414A5 (https=) | ||
| EP3893885A1 (en) | Active ester derivatives of testosterone, compositions and uses thereof | |
| PT563813E (pt) | Composicoes transdermicas | |
| CA2416709A1 (en) | Therapeutic agent for erectile dysfunction containing as the active ingredient prostaglandin derivatives | |
| EP1617827A1 (de) | Pharmazeutische zusammensetzung in form eines hydrogels zur transdermalen verabreichung von wirkstoffen | |
| MC2150A1 (fr) | Utilisation de derives d'acides alkylphophoriques pour la lutte contre les maladies du type psoriasis | |
| CN1501814A (zh) | 药物组合物 | |
| KR20050010014A (ko) | 유성 용액의 자기 투여 피임 주사 |